InvestorsHub Logo
Followers 36
Posts 2689
Boards Moderated 0
Alias Born 06/09/2011

Re: montanus post# 19976

Wednesday, 05/11/2016 11:49:46 AM

Wednesday, May 11, 2016 11:49:46 AM

Post# of 20775
Was this GSK trial done with ILNS Conjumab AMD program?

GSK completed GSK933776 (anti Aß peptide, n-terminus ) AMD phase 2 trial last month.
Enrolment: 190

https://clinicaltrials.gov/ct2/show/NCT01342926?term=gsk933776&rank=4

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.